Healthcare provider profile · identity verified

Raluca M Ionescu, MD

Internal Medicine · SPOKANE, WA · NPI 1497721211

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	434	122
Rosuvastatin Calcium	Rosuvastatin Calcium	409	121
Losartan Potassium	Losartan Potassium	404	111
Levothyroxine Sodium	Levothyroxine Sodium	340	93
Gabapentin	Gabapentin	304	90
Lisinopril	Lisinopril	294	80
Omeprazole	Omeprazole	260	80
Duloxetine Hcl	Duloxetine Hcl	256	68
Amlodipine Besylate	Amlodipine Besylate	252	76
Metoprolol Succinate	Metoprolol Succinate	214	63
Trazodone Hcl	Trazodone Hcl	192	64
Alendronate Sodium	Alendronate Sodium	176	57
Metformin Hcl Er	Metformin Hcl	155	47
Metformin Hcl	Metformin Hcl	128	39
Eliquis	Apixaban	121	29
Pantoprazole Sodium	Pantoprazole Sodium	121	27
Tamsulosin Hcl	Tamsulosin Hcl	111	33
Potassium Chloride	Potassium Chloride	108	40
Simvastatin	Simvastatin	105	29
Furosemide	Furosemide	101	36
Metoprolol Tartrate	Metoprolol Tartrate	93	21
Jardiance	Empagliflozin	86	31
Buspirone Hcl	Buspirone Hcl	82	21
Citalopram Hbr	Citalopram Hydrobromide	79	18
Bupropion Xl	Bupropion Hcl	78	23
Hydrochlorothiazide	Hydrochlorothiazide	76	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	73	21
Ozempic	Semaglutide	72	20
Allopurinol	Allopurinol	68	20
Albuterol Sulfate Hfa	Albuterol Sulfate	67	30
Famotidine	Famotidine	65	20
Escitalopram Oxalate	Escitalopram Oxalate	64	20
Mounjaro	Tirzepatide	63	15
Oxybutynin Chloride Er	Oxybutynin Chloride	61	22
Topiramate	Topiramate	61	22
Fluoxetine Hcl	Fluoxetine Hcl	55	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	14
Montelukast Sodium	Montelukast Sodium	52	17
Xarelto	Rivaroxaban	52	suppressed
Carvedilol	Carvedilol	51	14
Donepezil Hcl	Donepezil Hcl	45	suppressed
Pravastatin Sodium	Pravastatin Sodium	44	13
Sertraline Hcl	Sertraline Hcl	44	16
Tramadol Hcl	Tramadol Hcl	44	15
Atenolol	Atenolol	43	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	13
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Propranolol Hcl	Propranolol Hcl	41	15
Fluticasone Propionate	Fluticasone Propionate	40	14
Lovastatin	Lovastatin	37	13
Acyclovir	Acyclovir	36	13
Bupropion Hcl Sr	Bupropion Hcl	36	16
Ondansetron Odt	Ondansetron	36	16
Trulicity	Dulaglutide	36	14
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Meloxicam	Meloxicam	35	16
Clonidine Hcl	Clonidine Hcl	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	21
Lorazepam	Lorazepam	32	suppressed
Methylprednisolone	Methylprednisolone	32	31
Mirtazapine	Mirtazapine	32	suppressed
Synthroid	Levothyroxine Sodium	32	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	31	15
Prednisone	Prednisone	31	11
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Estradiol	Estradiol	27	12
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	15
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Spironolactone	Spironolactone	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	16
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Finasteride	Finasteride	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Glipizide	Glipizide	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Primidone	Primidone	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Zonisamide	Zonisamide	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Clomipramine Hcl	Clomipramine Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Modafinil	Modafinil	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error